title: 38th Annual Meeting of the International Society of Experimental Hematology.
abstract: The International Society of Experimental Hematology holds its annual meeting every northern summer. This year the meeting comprised of eight plenary sessions with distinguished invited speakers on in vivo imaging and tracking of hematopoietic stem cells (HSCs), HSC niches, epigenetic regulations of stem cells and regulation of stem cell fate, leukemogenesis, and mesenchymal stem cells. The small size of the meeting (300 attendees) permitted excellent discussion and face-to-face contacts between students, junior scientists and experts. Owing to the large number of keynote speakers, this report focuses on the most novel, unpublished data presented during the meeting.
authors.affiliation: Haematopoietic Stem Cell Laboratory, Mater Medical Research Institute, Aubigny Place, Raymond Terrace, South Brisbane, QLD 4101, Australia. jplevesque@mmri.mater.org.au
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Levesque
authors.forename: Ingrid G
authors.initials: IG
authors.lastname: Winkler
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000502:physiology; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage*; D057890:Epigenomics; D015870:Gene Expression; D006405:Hematology / Q000639:trends; D006410:Hematopoiesis / Q000235:genetics* / Q000276:immunology*; D006412:Hematopoietic Stem Cells / Q000276:immunology / Q000502:physiology; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007942:Leukemia, Experimental / Q000188:drug therapy* / Q000503:physiopathology*; D051379:Mice
chemical_list: D052246:Cyclooxygenase 2 Inhibitors